Geriatric Choosing Wisely choice of recommendations in France: a pragmatic approach based on clinical audits

• DOI: 10.1186/s12877-021-02619-7
• Publication Date: 2021-12-15T12:02:54Z
• Authors: T. Tannou; E. Menand; D. Veillard; J. Berthou Contreras; C. Slekovec; V. Daucourt; D. Somme; A. Corvol; ; T. Tannou; E. Menand; D. Veillard; D. Somme; A. Corvol
• Keywords: Clinical Audit; [SDV]Life Sciences [q-bio]; Research; RC952-954.6; 610; Choosing wisely; Clinical audit; [SDV] Life Sciences [q-bio]; 03 medical and health sciences; 0302 clinical medicine; Deprescribing; Geriatrics; Surveys and Questionnaires; 616; Humans; France; Aged; Antipsychotic Agents

Abstract Background The international Choosing Wisely campaign seeks to improve the appropriateness of care, notably through large campaigns among physicians and users designed to raise awareness of the risks inherent in overmedication.

Methods In deploying the Choosing Wisely campaign, the French Society of Geriatrics and Gerontology chose early operationalization via a tool for clinical audit over a limited area before progressive dissemination. This enabled validation of four consensual recommendations concerning the management of urinary tract infections, the prolonged use of anxiolytics, the use of neuroleptics in dementia syndromes, and the use of statins in primary prevention. The fifth recommendation concerns the importance of a dialogue on the level of care. It was written by patient representatives directly involved in the campaign.

Results The first cross-regional campaign in France involved 5337 chart screenings in 43 health facilities. Analysis of the results showed an important variability in practices between institutions and significant percentage of inappropriate prescriptions, notably of psychotropic medication.

Discussion The high rate of participation of target institutions shows that geriatrics professionals are interested in the evaluation and optimization of professional practices. Frequent overuse of psychotropic medication highlights the need of campaigns to raise awareness and encourage deprescribing.